Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

DECISIONS FOR THE CLINICIAN IN THE TREATMENT OF PANIC DISORDER - WHEN TO TREAT, WHICH TREATMENT TO USE, AND HOW LONG TO TREAT SYMP ON PANIC DISORDER : STRATEGIES FOR LONG-TERM TREATMENT / 1990 ANNUAL MEETING OF THE AMERICAN PSYCHIATRIC ASSOC Schatzberg, A. F., Ballenger, J. C. PHYSICIANS POSTGRADUATE PRESS. 1991: 26–31

Abstract

Issues in clinicians' decisions about initiation, selection, and duration of treatment for patients with panic disorder are reviewed. Panic disorder may entail considerable morbidity, particularly if left untreated. This observation, coupled with clinical experience that the benefits of pharmacologic treatment generally outweigh their risks, suggests that patients with panic disorder should be treated with medication. A decision tree for the acute and maintenance treatment of panic disorder patients is presented, and possible indications for both acute and maintenance treatments are discussed. The advantages and disadvantages of treatment with each of the three classes of drugs that have been found effective for panic disorder--the tricyclic antidepressants, the monoamine oxidase inhibitors, and the benzodiazepines--are reviewed.

View details for Web of Science ID A1991FB52600009

View details for PubMedID 1995599